Published in Tissue Eng Part A on April 25, 2011
Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc Natl Acad Sci U S A (2013) 1.29
Single-cell gene expression profiling reveals functional heterogeneity of undifferentiated human epidermal cells. Development (2013) 1.04
Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture. Stem Cell Reports (2014) 0.98
Systematic analysis of embryonic stem cell differentiation in hydrodynamic environments with controlled embryoid body size. Integr Biol (Camb) (2012) 0.96
Engineering three-dimensional stem cell morphogenesis for the development of tissue models and scalable regenerative therapeutics. Ann Biomed Eng (2013) 0.94
High-throughput fingerprinting of human pluripotent stem cell fate responses and lineage bias. Nat Methods (2013) 0.94
Rational bioprocess design for human pluripotent stem cell expansion and endoderm differentiation based on cellular dynamics. Biotechnol Bioeng (2011) 0.92
Engineering the human pluripotent stem cell microenvironment to direct cell fate. Biotechnol Adv (2013) 0.87
Fabrication of micropatterned polymeric nanowire arrays for high-resolution reagent localization and topographical cellular control. Nano Lett (2015) 0.87
Microwell regulation of pluripotent stem cell self-renewal and differentiation. Bionanoscience (2012) 0.86
Label-free electrophysiological cytometry for stem cell-derived cardiomyocyte clusters. Lab Chip (2012) 0.85
Emerging strategies for spatiotemporal control of stem cell fate and morphogenesis. Trends Biotechnol (2012) 0.83
Topological and electrical control of cardiac differentiation and assembly. Stem Cell Res Ther (2013) 0.83
Effects of 3D microwell culture on initial fate specification in human embryonic stem cells. AIChE J (2014) 0.83
Temporal modulation of β-catenin signaling by multicellular aggregation kinetics impacts embryonic stem cell cardiomyogenesis. Stem Cells Dev (2013) 0.80
Distinctive Roles of Canonical and Noncanonical Wnt Signaling in Human Embryonic Cardiomyocyte Development. Stem Cell Reports (2016) 0.78
A potential relationship among beta-defensins haplotype, SOX7 duplication and cardiac defects. PLoS One (2013) 0.78
Production of large numbers of size-controlled tumor spheroids using microwell plates. J Vis Exp (2013) 0.77
A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells. Stem Cells Transl Med (2015) 0.77
Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation. Arch Immunol Ther Exp (Warsz) (2016) 0.75
Quantitative multivariate analysis of dynamic multicellular morphogenic trajectories. Integr Biol (Camb) (2015) 0.75
Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells. J Vis Exp (2016) 0.75
Generating size-controlled embryoid bodies using laser direct-write. Biofabrication (2014) 0.75
Growth factors, matrices, and forces combine and control stem cells. Science (2009) 8.46
TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol (2008) 3.44
Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One (2008) 3.08
Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J (2007) 2.91
An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell (2011) 2.89
Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. Cell Stem Cell (2012) 2.58
Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells (2008) 2.34
Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods (2013) 2.14
Body surface projection of action potential duration alternans: a combined clinical-modeling study with implications for improving T-wave alternans detection. Heart Rhythm (2009) 2.11
Endocardial and epicardial repolarization alternans in human cardiomyopathy: evidence for spatiotemporal heterogeneity and correlation with body surface T-wave alternans. J Am Coll Cardiol (2007) 1.96
A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng Part A (2012) 1.95
Controlled, scalable embryonic stem cell differentiation culture. Stem Cells (2004) 1.87
Efficiency of embryoid body formation and hematopoietic development from embryonic stem cells in different culture systems. Biotechnol Bioeng (2002) 1.85
Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med (2012) 1.80
Anti-inflammatory and antiatherogenic role of BMP receptor II in endothelial cells. Arterioscler Thromb Vasc Biol (2013) 1.78
Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study. Am J Physiol Heart Circ Physiol (2005) 1.78
Ventricular fibrillation in myopathic human hearts: mechanistic insights from in vivo global endocardial and epicardial mapping. Am J Physiol Heart Circ Physiol (2007) 1.75
The systematic production of cells for cell therapies. Cell Stem Cell (2008) 1.71
Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol Bioeng (2009) 1.61
Prediction and testing of novel transcriptional networks regulating embryonic stem cell self-renewal and commitment. Cell Stem Cell (2007) 1.56
The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum Mol Genet (2002) 1.53
Escape capture bigeminy: phenotypic marker of cardiac sodium channel voltage sensor mutation R222Q. Heart Rhythm (2012) 1.53
Functional immobilization of signaling proteins enables control of stem cell fate. Nat Methods (2008) 1.52
Dynamic interaction networks in a hierarchically organized tissue. Mol Syst Biol (2010) 1.51
Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells (2005) 1.51
The effect of air pollution on spatial dispersion of myocardial repolarization in healthy human volunteers. J Am Coll Cardiol (2011) 1.49
Transmural IK(ATP) heterogeneity as a determinant of activation rate gradient during early ventricular fibrillation: mechanistic insights from rabbit ventricular models. Heart Rhythm (2013) 1.49
Cell-cell interaction networks regulate blood stem and progenitor cell fate. Mol Syst Biol (2009) 1.49
Real-time electrogram analysis for monitoring coronary blood flow during human ventricular fibrillation: implications for CPR. Heart Rhythm (2010) 1.42
Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc Natl Acad Sci U S A (2002) 1.38
A global assessment of stem cell engineering. Tissue Eng Part A (2014) 1.38
Role of NADPH oxidases in disturbed flow- and BMP4- induced inflammation and atherosclerosis. Antioxid Redox Signal (2006) 1.38
High-throughput generation of hydrogel microbeads with varying elasticity for cell encapsulation. Biomaterials (2010) 1.37
Alternative induced pluripotent stem cell characterization criteria for in vitro applications. Cell Stem Cell (2009) 1.36
Incorporation of biomaterials in multicellular aggregates modulates pluripotent stem cell differentiation. Biomaterials (2010) 1.35
Don't look: growing clonal versus nonclonal neural stem cell colonies. Stem Cells (2008) 1.33
Enabling stem cell therapies through synthetic stem cell-niche engineering. J Clin Invest (2010) 1.31
Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc Natl Acad Sci U S A (2013) 1.29
Development of a perfusion fed bioreactor for embryonic stem cell-derived cardiomyocyte generation: oxygen-mediated enhancement of cardiomyocyte output. Biotechnol Bioeng (2005) 1.28
Understanding cellular networks to improve hematopoietic stem cell expansion cultures. Curr Opin Biotechnol (2006) 1.25
High-throughput combinatorial cell co-culture using microfluidics. Integr Biol (Camb) (2011) 1.25
Spatial organization of embryonic stem cell responsiveness to autocrine gp130 ligands reveals an autoregulatory stem cell niche. Stem Cells (2006) 1.24
Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures. Nat Methods (2012) 1.23
Sensitivity analysis of intracellular signaling pathway kinetics predicts targets for stem cell fate control. PLoS Comput Biol (2007) 1.22
Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fibrillation in humans. Am J Physiol Heart Circ Physiol (2007) 1.21
LIF-mediated control of embryonic stem cell self-renewal emerges due to an autoregulatory loop. FASEB J (2007) 1.21
Coordinated regulation of endothelial nitric oxide synthase activity by phosphorylation and subcellular localization. Free Radic Biol Med (2006) 1.19
PERT: a method for expression deconvolution of human blood samples from varied microenvironmental and developmental conditions. PLoS Comput Biol (2012) 1.18
Universal scaling law of electrical turbulence in the mammalian heart. Proc Natl Acad Sci U S A (2007) 1.13
Sustained in vitro expansion of bone progenitors is cell density dependent. Stem Cells (2004) 1.12
Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue. Proc Natl Acad Sci U S A (2009) 1.10
Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6. Stem Cells (2002) 1.09
Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Exp Hematol (2005) 1.09
Intramural activation during early human ventricular fibrillation. Circ Arrhythm Electrophysiol (2011) 1.06
Phase mapping of cardiac fibrillation. Circ Arrhythm Electrophysiol (2010) 1.05
Role of KATP channels in the maintenance of ventricular fibrillation in cardiomyopathic human hearts. Circ Res (2011) 1.05
Manipulation of signaling thresholds in "engineered stem cell niches" identifies design criteria for pluripotent stem cell screens. PLoS One (2009) 1.03
Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. Exp Hematol (2003) 1.02
Micropatterning of human embryonic stem cells dissects the mesoderm and endoderm lineages. Stem Cell Res (2008) 1.01
The use of vascular endothelial growth factor functionalized agarose to guide pluripotent stem cell aggregates toward blood progenitor cells. Biomaterials (2010) 1.01
Predictive microfluidic control of regulatory ligand trajectories in individual pluripotent cells. Proc Natl Acad Sci U S A (2012) 1.00
Soluble Flt-1 regulates Flk-1 activation to control hematopoietic and endothelial development in an oxygen-responsive manner. Stem Cells (2008) 0.98
Blood stem cell fate regulation by Delta-1-mediated rewiring of IL-6 paracrine signaling. Blood (2013) 0.98
Systematic engineering of 3D pluripotent stem cell niches to guide blood development. Biomaterials (2011) 0.97
Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess. Biol Blood Marrow Transplant (2006) 0.96
HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity. Toxicol Appl Pharmacol (2012) 0.96
Supplementation-dependent differences in the rates of embryonic stem cell self-renewal, differentiation, and apoptosis. Biotechnol Bioeng (2003) 0.95
Electrogram fractionation in murine HL-1 atrial monolayer model. Heart Rhythm (2008) 0.94
High-throughput fingerprinting of human pluripotent stem cell fate responses and lineage bias. Nat Methods (2013) 0.94
A non-contact suspension culture approach to the culture of osteogenic cells derived from a CD49elow subpopulation of human bone marrow-derived cells. Biotechnol Bioeng (2007) 0.94
Creation of mouse embryonic stem cell-derived cardiac cell sheets. Biomaterials (2011) 0.93
Analysis of the temporal and concentration-dependent effects of BMP-4, VEGF, and TPO on development of embryonic stem cell-derived mesoderm and blood progenitors in a defined, serum-free media. Exp Hematol (2008) 0.92
Rational bioprocess design for human pluripotent stem cell expansion and endoderm differentiation based on cellular dynamics. Biotechnol Bioeng (2011) 0.92
Micro- and nanotechnology in cardiovascular tissue engineering. Nanotechnology (2011) 0.92
Clonal evolution of stem and differentiated cells can be predicted by integrating cell-intrinsic and -extrinsic parameters. Biotechnol Appl Biochem (2005) 0.91
Evolving electroanatomic substrate and intra-atrial reentrant tachycardia late after Fontan surgery. J Cardiovasc Electrophysiol (2011) 0.90
Phenotypic analysis of human embryonic stem cells. Curr Protoc Stem Cell Biol (2007) 0.90
Fiber alignment and coculture with fibroblasts improves the differentiated phenotype of murine embryonic stem cell-derived cardiomyocytes for cardiac tissue engineering. Biotechnol Bioeng (2011) 0.90
Oct4 is required ~E7.5 for proliferation in the primitive streak. PLoS Genet (2013) 0.89
The AC133+CD38-, but not the rhodamine-low, phenotype tracks LTC-IC and SRC function in human cord blood ex vivo expansion cultures. Blood (2009) 0.89
Letter by Nanthakumar and Waxman regarding article, "sudden cardiac arrest and death following application of shocks from a TASER electronic control device". Circulation (2013) 0.89
Effect of global ischemia and reperfusion during ventricular fibrillation in myopathic human hearts. Am J Physiol Heart Circ Physiol (2009) 0.88
Stem cell-based cardiac tissue engineering. J Cardiovasc Transl Res (2011) 0.88
Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle. Lab Chip (2014) 0.87
Mechanical inhibition of RANKL expression is regulated by H-Ras-GTPase. J Biol Chem (2005) 0.87
Synthetic peptide arrays for pathway-level protein monitoring by liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics (2010) 0.87
Engineered heart tissue enables study of residual undifferentiated embryonic stem cell activity in a cardiac environment. Biotechnol Bioeng (2010) 0.86
Development of a gene-trap vector with a highly sensitive fluorescent protein reporter system for expression profiling. Genesis (2008) 0.86